BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gluud LL, Vilstrup H, Morgan MY. Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta-analysis. Hepatology 2016;64:908-22. [PMID: 27081787 DOI: 10.1002/hep.28598] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Snehavardhan P, Lal BB, Sood V, Khanna R, Alam S. Efficacy and Safety of Sodium Benzoate in The Management of Hyperammonemia in Decompensated Chronic Liver Disease of the Childhood—A Double-blind Randomized Controlled Trial. Journal of Pediatric Gastroenterology & Nutrition 2020;70:165-70. [DOI: 10.1097/mpg.0000000000002521] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Coronel-castillo C, Contreras-carmona J, Frati-munari A, Uribe M, Méndez-sánchez N. Efficacy of rifaximin in the different clinical scenarios of hepatic encephalopathy. Revista de Gastroenterología de México (English Edition) 2020;85:56-68. [DOI: 10.1016/j.rgmxen.2019.09.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Madsen M, Kimer N, Bendtsen F, Petersen AM. Fecal microbiota transplantation in hepatic encephalopathy: a systematic review. Scand J Gastroenterol 2021;56:560-9. [PMID: 33840331 DOI: 10.1080/00365521.2021.1899277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bjerring PN, Morgan MY, Vilstrup H, Nielsen SM, Christensen R, Gluud LL; Cochrane Hepato-Biliary Group. Medical interventions for prevention and treatment of hepatic encephalopathy in adults with cirrhosis: a network meta-analysis. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd013241] [Reference Citation Analysis]
5 Tajiri K, Futsukaichi Y, Kobayashi S, Yasumura S, Takahara T, Minemura M, Sugiyama T. L-Carnitine for the Treatment of Overt Hepatic Encephalopathy in Patients with Advanced Liver Cirrhosis. J Nutr Sci Vitaminol (Tokyo) 2018;64:321-8. [PMID: 30381621 DOI: 10.3177/jnsv.64.321] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
6 Hasan LZ, Wu GY. Novel Agents in the Management of Hepatic Encephalopathy: A Review. J Clin Transl Hepatol 2021;9:749-59. [PMID: 34722190 DOI: 10.14218/JCTH.2021.00102] [Reference Citation Analysis]
7 Jalan R, Rose CF. Heretical thoughts into Hepatic Encephalopathy. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.03.014] [Reference Citation Analysis]
8 Gluud LL, Vilstrup H, Morgan MY. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst Rev. 2016;CD003044. [PMID: 27153247 DOI: 10.1002/14651858.cd003044.pub4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
9 Rajpurohit S, Musunuri B, Shailesh, Mohan PB, Shetty S. Novel Drugs for the Management of Hepatic Encephalopathy: Still a Long Journey to Travel. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.01.012] [Reference Citation Analysis]
10 Lu B, Wu C, Azami NLB, Xie D, Zhao C, Xu W, Hui D, Chen X, Sun R, Song J, An Y, Li K, Wang H, Ye G, Sun M. Babao Dan improves neurocognitive function by inhibiting inflammation in clinical minimal hepatic encephalopathy. Biomed Pharmacother 2021;135:111084. [PMID: 33383371 DOI: 10.1016/j.biopha.2020.111084] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Said VJ, Garcia-trujillo E. Beyond Lactulose: Treatment Options for Hepatic Encephalopathy. Gastroenterology Nursing 2019;42:277-85. [DOI: 10.1097/sga.0000000000000376] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang Z, Chu P, Wang W. Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy. Drug Des Devel Ther. 2019;13:1-11. [PMID: 30587923 DOI: 10.2147/dddt.s172324] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
13 Velarde-Ruiz Velasco JA, García-Jiménez ES, Aldana-Ledesma JM, Tapia-Calderón DK, Tornel-Avelar AI, Lazcano-Becerra M, Chávez-Ramírez RM, Cano-Contreras AD, Remes-Troche JM, Colunga-Lozano LE, Montaño-Loza A. Evaluation and management of emergencies in the patient with cirrhosis. Rev Gastroenterol Mex (Engl Ed) 2022:S2255-534X(22)00029-9. [PMID: 35570104 DOI: 10.1016/j.rgmxen.2022.05.001] [Reference Citation Analysis]
14 Weir V, Reddy KR. Nonpharmacologic Management of Hepatic Encephalopathy. Clinics in Liver Disease 2020;24:243-61. [DOI: 10.1016/j.cld.2020.01.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications. Clin Mol Hepatol 2020;26:83-127. [PMID: 31918536 DOI: 10.3350/cmh.2019.0010n] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
16 Wang JY, Bajaj JS, Wang JB, Shang J, Zhou XM, Guo XL, Zhu X, Meng LN, Jiang HX, Mi YQ, Xu JM, Yang JH, Wang BS, Zhang NP. Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial. J Dig Dis. 2019;20:547-556. [PMID: 31448533 DOI: 10.1111/1751-2980.12816] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
17 Yanny B, Winters A, Boutros S, Saab S. Hepatic Encephalopathy Challenges, Burden, and Diagnostic and Therapeutic Approach. Clin Liver Dis 2019;23:607-23. [PMID: 31563214 DOI: 10.1016/j.cld.2019.07.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Cremon C, Barbaro MR, Ventura M, Barbara G. Pre- and probiotic overview. Curr Opin Pharmacol. 2018;43:87-92. [PMID: 30219638 DOI: 10.1016/j.coph.2018.08.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 10.8] [Reference Citation Analysis]
19 Rathi S, Fagan A, Wade JB, Chopra M, White MB, Ganapathy D, Acharya C, Dhiman RK, Bajaj JS. Patient Acceptance of Lactulose Varies Between Indian and American Cohorts: Implications for Comparing and Designing Global Hepatic Encephalopathy Trials. J Clin Exp Hepatol 2018;8:109-15. [PMID: 29892171 DOI: 10.1016/j.jceh.2017.11.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
20 Kerbert AJC, Jalan R. Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease. F1000Res 2020;9:F1000 Faculty Rev-312. [PMID: 32399191 DOI: 10.12688/f1000research.22183.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Tani J, Morishita A, Sakamoto T, Takuma K, Nakahara M, Fujita K, Oura K, Tadokoro T, Mimura S, Nomura T, Yoneyama H, Kobara H, Himoto T, Masaki T. L-carnitine reduces hospital admissions in patients with hepatic encephalopathy. European Journal of Gastroenterology & Hepatology 2021;32:288-93. [DOI: 10.1097/meg.0000000000001748] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
22 Mishra S, Pallavi P. Diagnosis and Management of Pediatric Acute Liver Failure: ESPGHAN and NASPGHAN 2022. Indian Pediatr 2022;59:307-11. [DOI: 10.1007/s13312-022-2498-1] [Reference Citation Analysis]
23 Bai Z, Guo X, Tacke F, Li Y, Li H, Qi X. Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization. Therap Adv Gastroenterol 2019;12:1756284819881302. [PMID: 31636711 DOI: 10.1177/1756284819881302] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
24 Kornerup LS, Gluud LL, Vilstrup H, Dam G. Update on the Therapeutic Management of Hepatic Encephalopathy. Curr Gastroenterol Rep. 2018;20:21. [PMID: 29644492 DOI: 10.1007/s11894-018-0627-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
25 Olesen SS, Jackson CD, Morgan MY. Tools and tactics for improving the diagnosis of hepatic encephalopathy. J Hepatol 2017;66:1327-8. [PMID: 28215598 DOI: 10.1016/j.jhep.2017.01.034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
26 Labenz C, Kostev K, Galle PR, Wörns MA, Schattenberg JM. Prescription rates of common medications in patients with decompensated cirrhosis in Germany. Z Gastroenterol 2021. [PMID: 34820806 DOI: 10.1055/a-1676-4822] [Reference Citation Analysis]
27 Gupta T, Rathi S, K Dhiman R. Managing Encephalopathy in the Outpatient Setting. Euroasian J Hepatogastroenterol 2017;7:48-54. [PMID: 29201772 DOI: 10.5005/jp-journals-10018-1211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
28 Rudler M, Weiss N, Bouzbib C, Thabut D. Diagnosis and Management of Hepatic Encephalopathy. Clin Liver Dis 2021;25:393-417. [PMID: 33838857 DOI: 10.1016/j.cld.2021.01.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Shawcross DL. Diagnosis and management of hepatic encephalopathy. Br J Nurs 2018;27:S7-S13. [PMID: 29411990 DOI: 10.12968/bjon.2018.27.Sup3.S7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
30 Yang L, Bian X, Wu W, Lv L, Li Y, Ye J, Jiang X, Wang Q, Shi D, Fang D, Wu J, Wang K, Wang Q, Xia J, Xie J, Lu Y, Li L. Protective effect of Lactobacillus salivarius Li01 on thioacetamide-induced acute liver injury and hyperammonaemia. Microb Biotechnol 2020;13:1860-76. [PMID: 32652882 DOI: 10.1111/1751-7915.13629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Bai Z, Bernardi M, Yoshida EM, Li H, Guo X, Méndez-Sánchez N, Li Y, Wang R, Deng J, Qi X. Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis. Aging (Albany NY) 2019;11:8502-25. [PMID: 31596729 DOI: 10.18632/aging.102335] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
32 Kimer N, Gluud LL, Pedersen JS, Tavenier J, Møller S, Bendtsen F. The Psychometric Hepatic Encephalopathy Syndrome score does not correlate with blood ammonia, endotoxins or markers of inflammation in patients with cirrhosis. Transl Gastroenterol Hepatol 2021;6:8. [PMID: 33409402 DOI: 10.21037/tgh.2020.02.14] [Reference Citation Analysis]
33 Hadjihambi A, Arias N, Sheikh M, Jalan R. Hepatic encephalopathy a critical current review. Hepatol Int. 2018;12:135-147. [PMID: 28770516 DOI: 10.1007/s12072-017-9812-3] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 11.6] [Reference Citation Analysis]
34 Leger RF, Silverman MS, Hauck ES, Guvakova KD. Hyperammonemia Post Lung Transplantation: A Review. Clin Med Insights Circ Respir Pulm Med 2020;14:1179548420966234. [PMID: 33192115 DOI: 10.1177/1179548420966234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Mancini A, Campagna F, Amodio P, Tuohy KM. Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy. Food Funct. 2018;9:1373-1388. [PMID: 29485654 DOI: 10.1039/c7fo01528c] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
36 Chu YY, Wang X, Dai HL. Update on pharmacotherapy of hepatic encephalopathy. Shijie Huaren Xiaohua Zazhi 2021; 29(2): 58-64 [DOI: 10.11569/wcjd.v29.i2.58] [Reference Citation Analysis]
37 Squires JE, McKiernan P, Squires RH. Acute Liver Failure: An Update. Clin Liver Dis 2018;22:773-805. [PMID: 30266162 DOI: 10.1016/j.cld.2018.06.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]